» Articles » PMID: 12518062

Nitric Oxide-induced Cellular Stress and P53 Activation in Chronic Inflammation

Abstract

Free radical-induced cellular stress contributes to cancer during chronic inflammation. Here, we investigated mechanisms of p53 activation by the free radical, NO. NO from donor drugs induced both ataxia-telangiectasia mutated (ATM)- and ataxia-telangiectasia mutated and Rad3-related-dependent p53 posttranslational modifications, leading to an increase in p53 transcriptional targets and a G(2)M cell cycle checkpoint. Such modifications were also identified in cells cocultured with NO-releasing macrophages. In noncancerous colon tissues from patients with ulcerative colitis (a cancer-prone chronic inflammatory disease), inducible NO synthase protein levels were positively correlated with p53 serine 15 phosphorylation levels. Immunostaining of HDM-2 and p21(WAF1) was consistent with transcriptionally active p53. Our study highlights a pivotal role of NO in the induction of cellular stress and the activation of a p53 response pathway during chronic inflammation.

Citing Articles

Nitric Oxide Signaling and Sensing in Age-Related Diseases.

Mazuryk O, Gurgul I, Oszajca M, Polaczek J, Kieca K, Bieszczad-Zak E Antioxidants (Basel). 2024; 13(10).

PMID: 39456466 PMC: 11504650. DOI: 10.3390/antiox13101213.


Myeloid Mir34a suppresses colitis-associated colon cancer: characterization of mediators by single-cell RNA sequencing.

Konig J, Rokavec M, Oner-Ziegler M, Fei Y, Hermeking H Cell Death Differ. 2024; 32(2):225-241.

PMID: 39425000 PMC: 11802797. DOI: 10.1038/s41418-024-01380-9.


MDM2 induces pro-inflammatory and glycolytic responses in M1 macrophages by integrating iNOS-nitric oxide and HIF-1α pathways in mice.

Wu K, Xu X, Wu M, Li X, Hoque M, Li G Nat Commun. 2024; 15(1):8624.

PMID: 39366973 PMC: 11452520. DOI: 10.1038/s41467-024-53006-w.


Recognizing the role of Epstein-Barr virus in gastric cancer: transcriptomic insights into malignancy modulation.

Anbouhi T, Sazegar H, Rahimi E Virol J. 2024; 21(1):41.

PMID: 38355581 PMC: 10868016. DOI: 10.1186/s12985-024-02307-z.


Heterocyclic Molecular Targeted Drugs and Nanomedicines for Cancer: Recent Advances and Challenges.

Liu J, Chao T, Liu Y, Gong C, Zhang Y, Xiong H Pharmaceutics. 2023; 15(6).

PMID: 37376154 PMC: 10305175. DOI: 10.3390/pharmaceutics15061706.


References
1.
Hudson J, Shoaibi M, Maestro R, Carnero A, Hannon G, Beach D . A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med. 1999; 190(10):1375-82. PMC: 2195698. DOI: 10.1084/jem.190.10.1375. View

2.
Sarkaria J, Busby E, Tibbetts R, Roos P, Taya Y, Karnitz L . Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res. 1999; 59(17):4375-82. View

3.
Wang S, Guo M, Ouyang H, Li X, Cordon-Cardo C, Kurimasa A . The catalytic subunit of DNA-dependent protein kinase selectively regulates p53-dependent apoptosis but not cell-cycle arrest. Proc Natl Acad Sci U S A. 2000; 97(4):1584-8. PMC: 26478. DOI: 10.1073/pnas.97.4.1584. View

4.
Espey M, Miranda K, Pluta R, Wink D . Nitrosative capacity of macrophages is dependent on nitric-oxide synthase induction signals. J Biol Chem. 2001; 275(15):11341-7. DOI: 10.1074/jbc.275.15.11341. View

5.
Xu W, Liu L, Smith G, Charles L . Nitric oxide upregulates expression of DNA-PKcs to protect cells from DNA-damaging anti-tumour agents. Nat Cell Biol. 2000; 2(6):339-45. DOI: 10.1038/35014028. View